These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 17010341
1. Mechanism of hypoxia-specific cytotoxicity of procaspase-3 fused with a VHL-mediated protein destruction motif of HIF-1alpha containing Pro564. Harada H, Kizaka-Kondoh S, Hiraoka M. FEBS Lett; 2006 Oct 16; 580(24):5718-22. PubMed ID: 17010341 [Abstract] [Full Text] [Related]
2. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein. Yu F, White SB, Zhao Q, Lee FS. Cancer Res; 2001 May 15; 61(10):4136-42. PubMed ID: 11358837 [Abstract] [Full Text] [Related]
3. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Yu F, White SB, Zhao Q, Lee FS. Proc Natl Acad Sci U S A; 2001 Aug 14; 98(17):9630-5. PubMed ID: 11504942 [Abstract] [Full Text] [Related]
4. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor. Koshikawa N, Takenaga K. Cancer Res; 2005 Dec 15; 65(24):11622-30. PubMed ID: 16357173 [Abstract] [Full Text] [Related]
6. Significance of HIF-1-active cells in angiogenesis and radioresistance. Harada H, Kizaka-Kondoh S, Li G, Itasaka S, Shibuya K, Inoue M, Hiraoka M. Oncogene; 2007 Nov 29; 26(54):7508-16. PubMed ID: 17563752 [Abstract] [Full Text] [Related]
8. Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions. Jung YS, Lee SJ, Yoon MH, Ha NC, Park BJ. Cell Cycle; 2012 Dec 01; 11(23):4462-73. PubMed ID: 23159849 [Abstract] [Full Text] [Related]
10. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. Tanimoto K, Makino Y, Pereira T, Poellinger L. EMBO J; 2000 Aug 15; 19(16):4298-309. PubMed ID: 10944113 [Abstract] [Full Text] [Related]
12. Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53. Cho IR, Koh SS, Min HJ, Park EH, Ratakorn S, Jhun BH, Jeong SH, Yoo YH, Youn HD, Johnston RN, Chung YH. Cancer Gene Ther; 2010 May 15; 17(5):365-72. PubMed ID: 20075985 [Abstract] [Full Text] [Related]
14. Molecular basis for the regulation of hypoxia-inducible factor-1α levels by 2-deoxy-D-ribose. Ikeda R, Tabata S, Tajitsu Y, Nishizawa Y, Minami K, Furukawa T, Yamamoto M, Shinsato Y, Akiyama S, Yamada K, Takeda Y. Oncol Rep; 2013 Sep 15; 30(3):1444-8. PubMed ID: 23807085 [Abstract] [Full Text] [Related]
15. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription. Ampofo E, Kietzmann T, Zimmer A, Jakupovic M, Montenarh M, Götz C. Int J Biochem Cell Biol; 2010 Oct 15; 42(10):1729-35. PubMed ID: 20637892 [Abstract] [Full Text] [Related]
17. ATP6V0C competes with von Hippel-Lindau protein in hypoxia-inducible factor 1alpha (HIF-1alpha) binding and mediates HIF-1alpha expression by bafilomycin A1. Lim JH, Park JW, Kim SJ, Kim MS, Park SK, Johnson RS, Chun YS. Mol Pharmacol; 2007 Mar 15; 71(3):942-8. PubMed ID: 17178925 [Abstract] [Full Text] [Related]